These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23543780)

  • 21. Breast cancer and hormone-replacement therapy in the Million Women Study.
    Crosignani PG
    Maturitas; 2003 Oct; 46(2):91-2. PubMed ID: 14559371
    [No Abstract]   [Full Text] [Related]  

  • 22. Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada.
    Kirsh V; Kreiger N
    Cancer Causes Control; 2002 Aug; 13(6):583-90. PubMed ID: 12195648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of oestrogens and progestin and the risk of breast cancer in post-menopausal women. G.A. Colditz et al. N. Engl. J. Med. 1995; 332: 1589-93.
    Kauppila A
    Pharmacol Res; 1995 Dec; 32(6):327. PubMed ID: 8736481
    [No Abstract]   [Full Text] [Related]  

  • 24. Risk of breast cancer among users of estrogen plus progestogen and unopposed estrogen: is the likelihood of bias symmetrical?
    Shapiro S
    Climacteric; 2015 Jun; 18(3):333-5. PubMed ID: 25651904
    [No Abstract]   [Full Text] [Related]  

  • 25. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study outlines further risks associated with hormone replacement therapy.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Sep; 14(17):1-2, 5. PubMed ID: 13677336
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk of breast cancer with HRT depends on therapy type and duration.
    Saul H; Gursul D; Cassidy S; Vinogradova Y
    BMJ; 2022 Mar; 376():o485. PubMed ID: 35260385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some comments on the Million Women Study.
    Neves-E-Castro M
    Climacteric; 2003 Dec; 6(4):357. PubMed ID: 15006258
    [No Abstract]   [Full Text] [Related]  

  • 30. Hormone replacement and breast cancer. A remaining controversy?
    Adami HO; Persson I
    JAMA; 1995 Jul; 274(2):178-9. PubMed ID: 7596008
    [No Abstract]   [Full Text] [Related]  

  • 31. Critical review of the article by Colditz et al. on 'The use of estrogens and progestins and the risk of breast cancer in postmenopausal women' published in the N.E.J.M. 1995, 332: 1589.
    Sismondi P; Biglia N
    Pharmacol Res; 1995 Dec; 32(6):329-30. PubMed ID: 8736482
    [No Abstract]   [Full Text] [Related]  

  • 32. Postmenopausal estrogen-progestin therapy and breast cancer: a clinical response to epidemiological reports.
    Speroff L
    Climacteric; 2000 Mar; 3(1):3-12. PubMed ID: 11910607
    [No Abstract]   [Full Text] [Related]  

  • 33. Understanding breast density and breast cancer risk.
    Peres J
    J Natl Cancer Inst; 2012 Sep; 104(18):1345-6. PubMed ID: 22984197
    [No Abstract]   [Full Text] [Related]  

  • 34. Does post-menopausal hormone-replacement therapy increase risk for breast cancer? A perspective on the findings of the Nurses' Health Study.
    Herd JA; Gotto AM
    Pharmacol Res; 1995 Dec; 32(6):331-3. PubMed ID: 8736483
    [No Abstract]   [Full Text] [Related]  

  • 35. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk.
    Rebbeck TR; Troxel AB; Shatalova EG; Blanchard R; Norman S; Bunin G; Demichele A; Schinnar R; Berlin JA; Strom BL
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1318-20. PubMed ID: 17548708
    [No Abstract]   [Full Text] [Related]  

  • 36. Progestins and breast cancer.
    Eden J
    Am J Obstet Gynecol; 2003 May; 188(5):1123-31. PubMed ID: 12748456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmenopausal estrogens--opposed, unopposed, or none of the above.
    Willett WC; Colditz G; Stampfer M
    JAMA; 2000 Jan; 283(4):534-5. PubMed ID: 10659883
    [No Abstract]   [Full Text] [Related]  

  • 38. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
    Nozaki M; Koera K; Nagata H; Nakano H
    J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of hormone replacement therapy after mastectomy.
    Del Mar CB; Glasziou PP; Spinks AB; Sanders SL; Hilton DJ
    Med J Aust; 2002 Mar; 176(6):285. PubMed ID: 11999265
    [No Abstract]   [Full Text] [Related]  

  • 40. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States).
    Schairer C; Byrne C; Keyl PM; Brinton LA; Sturgeon SR; Hoover RN
    Cancer Causes Control; 1994 Nov; 5(6):491-500. PubMed ID: 7827235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.